Last reviewed · How we verify
NCT03476005
Proficiency Based Training to Investigate WBIT
NA trial testing proficiency based progression training in Transfusion Related Complication in 94 participants. Completed in 3 July 2018.
3 July 2018
Quick facts
| Lead sponsor | Patrick Henn |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 94 |
| Start date | 5 July 2017 |
| Primary completion | 3 July 2018 |
| Estimated completion | 3 July 2018 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- proficiency based progression training
Conditions studied
- Transfusion Related Complication — all drugs for Transfusion Related Complication →
- Wrong Blood in Tube — all drugs for Wrong Blood in Tube →
Sponsor
Patrick Henn
Who can join
Eligibility, any sex, with Transfusion Related Complication or Wrong Blood in Tube. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Incorrect labelling of blood samples occurs at a rate of 1% in the general laboratories and 6% in Blood Transfusion Laboratories. The most serious error 'Wrong Blood in Tube' (WBIT) occurs when blood is taken from the intended patient, but labelled with another patient's details. Consequences may include, misinterpretation of a patient's diagnosis or clinical status, incorrect referral or treatment of a patient, or in the worst case scenario, incorrect cross matching for blood of the wrong blood group, which may lead to catastrophic outcomes, including death. The root causes for these errors is failure to identify the patient correctly and failure to correctly label the blood tubes at the bedside. To date, despite significant initiatives, it has proved very difficult to eradicate or reduce the error rate. Our project involves a novel, technology enhanced learning approach using proficiency based progression in a prospective randomised controlled methodology to significantly reduce this error. This approach to learning is more efficient and effective than the traditional approach of repeated practice and is made possible with metric-based simulations. This project will reduce the incidence of adverse events and avoidable medical errors associated with sampling and labelling errors including WBITs. This will be achieved by training healthcare practitioners to a proficiency standard in venepuncture. Thereby minimising the failure of health care professionals to identify the patient correctly and failure to correctly label the blood tubes at the bedside. This project's impact will deliver reduced sampling and labelling errors -including WBITs by a factor of 40-69%. Reductions of this magnitude will have profound national and international implications on how these types of skills are acquired and quality assured. This would result in improved patient safety and savings of over €500,000 at Cork University Hospital and if applied nationally result in exchequer savings of millions of euro annually.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03476005
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Transfusion Related Complication
Currently open trials in the same condition.
- NCT06399536 — Individualized ANH for Non-cardiac Surgery · NA · recruiting
- NCT05806346 — Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery · NA · recruiting
- NCT06403163 — Transfusion Surveillance in Anaesthesia · recruiting
- NCT03999229 — S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion · Phase 1 · recruiting
Other Patrick Henn trials
Trials by the same sponsor.
- NCT03577561 — Proficiency Based Training to Investigate Blood Sampling Errors Including WBIT · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03476005 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Patrick Henn
- Last refreshed: 5 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03476005.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing